tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market

BridgeBio Pharma (BBIO) Cash flow

Compare
1,429 Followers

BridgeBio Pharma Cash Flow

BBIO's free cash flow for Q3 2025 was $-110.04M. For the 2025 fiscal year, BBIO's free cash flow was decreased by $7.37M and operating cash flow was $-109.57M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -520.73M$ -527.72M$ -419.49M$ -497.93M$ -399.71M
Investing Cash Flow
$ 60.78M$ 54.03M$ 453.15M$ -200.83M$ -52.99M
Financing Cash Flow
$ 748.46M$ 451.54M$ -13.13M$ 736.45M$ 447.19M
End Cash Position
$ 683.24M$ 394.73M$ 416.88M$ 396.37M$ 358.68M
Free Cash Flow
$ -521.66M$ -529.03M$ -425.81M$ -546.18M$ -407.23M
Currency in USD

BridgeBio Pharma Cash Flow